Sort
21,453 grants matching “tuberculosis”
Epidemiology and molecular mechanisms of anthelminthic treatment failure in Kinta
$103,829Michael D Wilson · Noguchi Memorial Institute / Medical Res · R01 · FY2016 · AI
Bacterial Sensing and Response to Chloride as a Novel Tuberculosis Drug Target
$103,648Shumin Tan · Cornell University · K99 · FY2015 · AI
TESTING OF LIVE ATTENUATED STRAINS OF M TUBERCULOSIS
$103,634Barry R Bloom · Harvard Medical School · P51 · FY2007 · RR
Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)
$103,627Jessica L Castilho · Vanderbilt University Medical Center · U01 · FY2025 · AI
Core I: Pharmacology Core
$103,599Francesca T. Aweeka · University Of California, San Francisco · P30 · FY2021 · AI
Haiti AIDS Research Training: Models to Implementation
$103,551Jean William Pape · Gheskio Center · U2R · FY2008 · TW
Investigation of responses to Mycobacterium tuberculosis complex lineages by different African host population: Implications for host-directed therapies
$103,398Leopold Tientcheu Djomkam · Medical Research Council Unit The Gambia At The London School Of Hygiene & Tropical Medicine · K43 · FY2019 · TW
Antibodies associated with protection against tuberculosis in nonhuman primates
$103,387Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R21 · FY2018 · AI
Characterizing the pharmacokinetics of high dose rifampicin and linezolid in a randomized controlled trial for HIV-associated tuberculous meningitis
$103,369Sean Adam Wasserman · University Of Cape Town · K43 · FY2021 · TW
LEICA EM UC/6 CRYO-ULTRAMICROTOME AND ACCESSORIES
$103,338University Of California Berkeley · S10 · FY2005 · RR
The UCSD CD4 Collaborative Clinical Trial Unit
$103,303Constance Ann Benson · University Of California, San Diego · UM1 · FY2015 · AI
Sigma factor networks of M. tuberculosis
$103,215Maria Laura Gennaro · Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2012 · AI
An Efficient Bacterial Vector-Based Tuberculosis Vaccine
$102,900Veterinary Technologies Corporation · R43 · FY2001 · AI
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy
$102,841William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Dolutegravir for the treatment of HIV in patients with Tuberculosis in KwaZulu-Natal South Africa
$102,834Anushka Naidoo · Centre/Aids Programme/Res/South Africa · K43 · FY2019 · TW
Inter-American E-Capacity Research Training in Infectious and Chronic Diseases
$102,792Richard A Oberhelman · Tulane University Of Louisiana · R25 · FY2016 · TW
Inter-American E-Capacity Research Training in Infectious and Chronic Diseases
$102,790Richard A Oberhelman · Tulane University Of Louisiana · R25 · FY2015 · TW
Husbandry and Management Core
$102,711Kamm Prongay · Oregon Health & Science University · U42 · FY2024 · OD
Patient and system factors associated with successful treatment of Tuberculosis
$102,676Fernando Adriãn Rubinstein · Instituto De Efectividad Clinica Y Sanit · R01 · FY2011 · AI
Mechanism and physiology of DUF1222-assisted lipase maturation
$102,598Saskia Neher · University Of California, San Francisco · K99 · FY2010 · HL
BIOCHEMISTRY AND HEPATIC TOXICITY OF CARBON RADICALS
$102,546Paul R Ortiz De Montellano · University Of California, San Francisco · R01 · FY2008 · GM
POINT-OF-CARE BREATH TEST FOR DISEASES
$102,499Michael Phillips · Menssana Research, Inc. · R43 · FY2010 · RR
Multidisciplinary Training in Tuberculosis
$102,466Johns Hopkins University · T32 · FY2001 · AI
Host-Pathogen Interactions and M.tb Drug Resistance
$102,386Gilla Kaplan · Public Health Research Institute · R01 · FY2006 · AI
Mechanisms of Immune Regulation in Mycobacterium Tuberculosis Infection
$102,328Cheryl Liane Day · University Of Cape Town · R01 · FY2011 · AI